EmCyte, the world leader in platelet rich plasma and progenitor stem cell biologics, announces the acquisition of all of the assets of Cellmedix Holdings LLC, including the Centrepid Platelet Concentrator system. This acquisition bolsters the intellectual property profile of EmCyte Corporation and expands its product development capabilities. EmCyte’s mission of providing the most powerful and effective autologous regenerative biologics continues with bold new ideas.
Read the full article: EmCyte Announces the Acquisition of the Centrepid Platelet Concentrator //
Source: https://www.prnewswire.com/news-releases/emcyte-announces-the-acquisition-of-the-centrepid-platelet-concentrator-301007943.html